Summary
51 / 100 · Bulios Score
Valuation 100Growth 72Profitability 8Quality 7Debt 69Stability 62
What speaks for it
- Revenue grew by 7.1% a year over the last 3 years.
- It holds more cash than debt: $1.47M against $152.6K.
What to watch
- The company made a loss over the last 12 months.
- It passes only 1 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapThe company made a loss over the last 12 months, so there is no profit to set the price against.
Valuation in detailIs it growing?
Yes, fastRevenue (CAD)
20222023202420252026
Diluted EPS (CAD)
20222023202420252026
Revenue grew by 9.4% a year over 5 years. Over the last 3 years it grew by 7.1% a year.
Growth in detailDoes it make money?
PoorlyOver the last 12 months it made a loss of $635.0K.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $1.58M
Debt $152.6K
Free cash flow over 12 months -$1.54M
Over the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.